- Home
- MRKR vs GORV Comparison
MRKR vs GORV Comparison
Compare MRKR & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- GORV
- Stock Information
- Founded
- MRKR N/A
- GORV 1976
- Country
- MRKR United States
- GORV United States
- Employees
- MRKR N/A
- GORV N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- GORV Retail-Auto Dealers and Gas Stations
- Sector
- MRKR Health Care
- GORV Consumer Discretionary
- Exchange
- MRKR Nasdaq
- GORV Nasdaq
- Market Cap
- MRKR 13.7M
- GORV 15.5M
- IPO Year
- MRKR N/A
- GORV 2015
- Fundamental
- Price
- MRKR $0.89
- GORV $2.85
- Analyst Decision
- MRKR Strong Buy
- GORV
- Analyst Count
- MRKR 3
- GORV 0
- Target Price
- MRKR $13.17
- GORV N/A
- AVG Volume (30 Days)
- MRKR 2.6M
- GORV 52.9K
- Earning Date
- MRKR 08-14-2025
- GORV 08-14-2025
- Dividend Yield
- MRKR N/A
- GORV N/A
- EPS Growth
- MRKR N/A
- GORV N/A
- EPS
- MRKR N/A
- GORV N/A
- Revenue
- MRKR $5,388,071.00
- GORV $662,952,000.00
- Revenue This Year
- MRKR N/A
- GORV $15.65
- Revenue Next Year
- MRKR $15.82
- GORV $20.54
- P/E Ratio
- MRKR N/A
- GORV N/A
- Revenue Growth
- MRKR 44.55
- GORV N/A
- 52 Week Low
- MRKR $0.81
- GORV $2.52
- 52 Week High
- MRKR $5.95
- GORV $58.80
- Technical
- Relative Strength Index (RSI)
- MRKR 30.85
- GORV 23.63
- Support Level
- MRKR $0.81
- GORV $2.52
- Resistance Level
- MRKR $0.98
- GORV $4.05
- Average True Range (ATR)
- MRKR 0.10
- GORV 0.38
- MACD
- MRKR -0.03
- GORV 0.01
- Stochastic Oscillator
- MRKR 14.39
- GORV 14.16
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.